93
These are all diseases and symptoms that we would like to look at and potentially use cannabis and cannabinoids as a treatment option. Chronic inflammation is rife throughout many medical conditions and syndromes, and it would be good to look at CBD or any secondary cannabinoid that is an immune modulatory and an anti-inflammatory – could be what drives that market.
Trevor, cannabis has been said to be an effective as a substitute or replacement for pharmaceuticals or to get people off opioids. Is this something that OneLeaf is looking at getting into clinical trials using beverages?
Absolutely. We already have some R&D in the works with research institutions and academic institutions and that is why we brought Dr. Guppy on board … someone with his skill sets is the only way to accomplish this. I definitely see us pursuing this in conjunction with beverages in the adult recreational market.
Cheers. In time, OneLeaf may look at outside grow … how do you address GMP and other regulations is an outdoor grow model?
Genetics and cultivars are key and everything starts there. With the right protocols in place and the right genetic catalogue, such as what OneLeaf has, outdoor grow cannabis can meet these regulatory requirements. Stabilizing cultivars is #1 strategy. Dr. Guppy can speak to this …
So … once again “quality is currency” and quality genetics is … is gold …